Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PTC THERAPEUTICS, INC.PTCT · Entity 3803 | SVP, CHIEF ACCOUNTING OFFICER | June 17, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PTC THERAPEUTICS, INC.
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,199 |
Ending reported balance
After 2026-06-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-17 · Exercise / conversion · Acquired 19,686 · Balance 89,885 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. Row 2 · 2026-06-17 · Sale · Disposed 19,686 · Balance 70,199 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.69 · Expires 2034-02-14 | Direct | 15,314 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Exercise / conversion · Disposed 19,686 · Balance 15,314 F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. F2: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026.
F2: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2023 Filed Feb 2, 2023 21:23 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 325 | $45.63 | $14,829.10 |
DisclosureSEC source: 0001415889-23-001804 · form4-02022023_090225.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,059 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs. Read SEC document |
| January 11, 2023 Filed Jan 12, 2023 21:33 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 417 | $44.36 | $18,497.95 |
DisclosureSEC source: 0001415889-23-000876 · form4-01122023_090117.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,384 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:33 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 489 | $42.93 | $20,994.19 |
DisclosureSEC source: 0001415889-23-000876 · form4-01122023_090117.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,801 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 23:10 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 706 | $41.66 | $29,409.28 |
DisclosureSEC source: 0001415889-23-000833 · form4-01112023_110128.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,290 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:58 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 32,500 | $0.00 Strike: $39.42 | $0.00 |
DisclosureSEC source: 0001415889-23-000694 · form4-01092023_090148.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2033-01-04 F2 · derivative.exercise_date: This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 21:58 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000694 · form4-01092023_090148.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,996 F1 · balance_after: Includes 293 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 21:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 707 | $40.38 | $28,548.66 |
DisclosureSEC source: 0001179110-22-000841 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,405 F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:59 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 313 | $40.00 | $12,520.63 |
DisclosureSEC source: 0001179110-22-000841 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,112 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:50 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $18.01 Strike: $18.01 | $180,100.00 |
DisclosureSEC source: 0001104659-22-005976 · tm224053-1_4seq1.xml · derivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:50 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 10,000 | $44.00 | $440,000.00 |
DisclosureSEC source: 0001104659-22-005976 · tm224053-1_4seq1.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,425 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:50 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 10,000 | $18.01 | $180,100.00 |
DisclosureSEC source: 0001104659-22-005976 · tm224053-1_4seq1.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:50 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 1,428 | $43.50 | $62,118.00 |
DisclosureSEC source: 0001104659-22-005976 · tm224053-1_4seq1.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,425 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2021. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:21 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 43,500 | $0.00 Strike: $38.10 | $0.00 |
DisclosureSEC source: 0001179110-22-000401 · edgar.xml · derivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Stock · 43,500 shares Expires 2032-01-06 F4 · derivative.exercise_date: This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:21 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 11,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000401 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,853 F3 · shares: Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:21 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 747 | $38.53 | $28,778.18 |
DisclosureSEC source: 0001179110-22-000401 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,253 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs. F2 · balance_after: Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:24 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,657 | $33.02 Strike: $33.02 | $87,734.14 |
DisclosureSEC source: 0001179110-21-001510 · edgar.xml · derivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 2,657 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. F2 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:24 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,657 | $66.00 | $175,362.00 |
DisclosureSEC source: 0001179110-21-001510 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,509 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 21:24 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,657 | $33.02 | $87,734.14 |
DisclosureSEC source: 0001179110-21-001510 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 12:46 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 652 | $57.64 | $37,581.28 |
DisclosureSEC source: 0001179110-21-001131 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,509 F2 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 12:46 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 368 | $56.96 | $20,959.81 |
DisclosureSEC source: 0001179110-21-001131 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,161 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $18.01 Strike: $18.01 | $45,025.00 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · derivative · entry 7 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 2,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. F3 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 788 | $11.23 Strike: $11.23 | $8,849.24 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · derivative · entry 6 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 788 shares Expires 2027-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,500 | $66.57 | $166,425.00 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · nonDerivative · entry 5 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,529 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,500 | $18.01 | $45,025.00 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · nonDerivative · entry 4 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 788 | $66.57 | $52,457.16 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · nonDerivative · entry 3 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,529 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 788 | $11.23 | $8,849.24 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 21:04 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 659 | $66.57 | $43,869.63 |
DisclosureSEC source: 0001179110-21-000648 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,529 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:14 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantStock Option (Right to Buy) · Derivative | 50,750 | $0.00 Strike: $66.49 | $0.00 |
DisclosureSEC source: 0001179110-21-000468 · edgar.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,750 Underlying: Common Stock · 50,750 shares Expires 2031-01-05 F2 · derivative.exercise_date: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 22:14 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | GrantCommon Stock | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000468 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,188 F1 · shares: Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:55 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 316 | $62.37 | $19,708.92 |
DisclosureSEC source: 0001179110-21-000412 · edgar.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,488 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs. F2 · balance_after: Includes 242 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,656 | $33.02 Strike: $33.02 | $87,701.12 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 27 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,907 Underlying: Common Stock · 2,656 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F4 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,625 | $33.02 Strike: $33.02 | $350,837.50 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 26 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,563 Underlying: Common Stock · 10,625 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F4 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,656 | $33.02 Strike: $33.02 | $87,701.12 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 25 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,188 Underlying: Common Stock · 2,656 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F4 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 2,656 | $33.02 Strike: $33.02 | $87,701.12 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 24 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,844 Underlying: Common Stock · 2,656 shares Expires 2029-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F4 · derivative.exercise_date: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,055 | $30.86 Strike: $30.86 | $248,577.30 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 23 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,055 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $18.01 Strike: $18.01 | $45,025.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 22 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 2,500 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F3 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 355 | $18.01 Strike: $18.01 | $6,393.55 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 21 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 355 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F3 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right to Buy) · Derivative | 688 | $30.86 Strike: $30.86 | $21,231.68 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 20 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055 Underlying: Common Stock · 688 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionStock Option (Right To Buy) · Derivative | 1,567 | $30.86 Strike: $30.86 | $48,357.62 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · derivative · entry 19 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,743 Underlying: Common Stock · 1,567 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. F2 · derivative.exercise_date: Currently exercisable. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,656 | $60.00 | $159,360.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 18 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,656 | $33.02 | $87,701.12 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 17 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 10,625 | $60.00 | $637,500.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 16 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 10,625 | $33.02 | $350,837.50 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 15 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,656 | $60.00 | $159,360.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 14 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,656 | $33.02 | $87,701.12 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 13 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,656 | $60.00 | $159,360.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 12 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 2,656 | $33.02 | $87,701.12 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 11 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 8,055 | $60.20 | $484,911.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 10 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | Exercise / conversionCommon Stock | 8,055 | $30.86 | $248,577.30 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 9 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:35 UTC | PTC THERAPEUTICS, INC. PTCT · Entity 3803 | SaleCommon Stock | 2,500 | $60.00 | $150,000.00 |
DisclosureSEC source: 0001179110-20-010870 · edgar.xml · nonDerivative · entry 8 Utter Christine Marie · CIK 0001707685 · SVP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,562 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.